Literature DB >> 6430644

Economic analysis and clinical trials.

M F Drummond, G L Stoddart.   

Abstract

Given the increasing interest in the economics of health care, the incorporation of economic analysis in clinical trials is more often being considered, both by medical researchers and by research funding bodies. This article proposes criteria for judging the appropriateness of including economic analysis in a given trial, suggests how that analysis could be phased in order to minimize the work involved, and discusses the wider implications for medical research of more frequent attention to economic concepts.

Mesh:

Year:  1984        PMID: 6430644     DOI: 10.1016/0197-2456(84)90118-1

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  28 in total

Review 1.  How should cost data in pragmatic randomised trials be analysed?

Authors:  S G Thompson; J A Barber
Journal:  BMJ       Date:  2000-04-29

2.  Randomized controlled trial and economic evaluation.

Authors:  S Jain; N K Arora
Journal:  Indian J Pediatr       Date:  2000-05       Impact factor: 1.967

3.  Economic analysis of randomized, controlled trials.

Authors:  G H Lyman
Journal:  Curr Oncol Rep       Date:  2001-09       Impact factor: 5.075

Review 4.  Testing the validity of cost-effectiveness models.

Authors:  C McCabe; S Dixon
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

5.  Clinical economics: a method for prospective health resource data collection.

Authors:  C Copley-Merriman; L Egbuonu-Davis; J G Kotsanos; P Conforti; T Franson; G Gordon
Journal:  Pharmacoeconomics       Date:  1992-05       Impact factor: 4.981

Review 6.  Cost effectiveness of surfactant replacement in preterm babies.

Authors:  M Mugford; S Howard
Journal:  Pharmacoeconomics       Date:  1993-05       Impact factor: 4.981

7.  Cost-effectiveness analysis: obstacles to standardisation and its use in regulating pharmaceuticals.

Authors:  B R Luce
Journal:  Pharmacoeconomics       Date:  1993-01       Impact factor: 4.981

8.  The cost of migraine: more than just a headache?

Authors:  P J Davey; S R Leeder
Journal:  Pharmacoeconomics       Date:  1992-07       Impact factor: 4.981

9.  Indices of therapeutic outcome in pharmacoeconomic evaluation of drug therapy.

Authors:  S F Hurley
Journal:  Pharmacoeconomics       Date:  1992-03       Impact factor: 4.981

Review 10.  Analysis and interpretation of cost data in randomised controlled trials: review of published studies.

Authors:  J A Barber; S G Thompson
Journal:  BMJ       Date:  1998-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.